According to Bespak parent company Consort Medical, Bespak will construct a new dedicated facility at it's King's Lynn, UK site in order to meet production demands after signing a contract to manufacture a proprietary dry powder inhaler. The multi-year contract relates to a development project known as DEV610 for "a global pharma company whose details remain … [Read more...] about Bespak gets DPI contract
News
Study finds out-of-hospital intranasal fentanyl safe and effective
A study by Danish researchers published online November 25, 2013 by the Annals of Emergency Medicine found that intranasal fentanyl administered by ambulance workers prior to delivery of patients to the hospital appeared to be safe and effective. The study involved over 900 patients, including adults and children older than 8, who were in severe pain. The patients … [Read more...] about Study finds out-of-hospital intranasal fentanyl safe and effective
Inhaled drug start-up Pulmocide gets £17 million in funding
Imperial Innovations Group has announced that it is contributing £4.25 million towards a total of £17 million ($27.5 million) in funding for a new inhaled drug discovery and development company called Pulmocide. Other investors in the consortium include SV Life Sciences, Fidelity Biosciences, and Johnson & Johnson Development Corporation. The new London-based … [Read more...] about Inhaled drug start-up Pulmocide gets £17 million in funding
Copley to introduce Child Alberta Idealised Throat at DDL
Copley Scientific has announced that it will introduce the new Child Alberta Idealised Throat for inhaler testing at Drug Delivery to the Lungs 24 along with its recently introduced TPK-R critical flow controller. The child version of the Alberta Idealised Throat (AIT) is designed to provide cascade impactor data with greater in vivo relevance for pediatric … [Read more...] about Copley to introduce Child Alberta Idealised Throat at DDL
Japanese launches for Flutiform, Ultibro
Two inhalation combination products have been launched in Japan within a day of each other. Skyepharma has announced that its Japanese partner Kyorin launched a 56-inhalation version of the Flutiform fluticasone/formoterol MDI, and Sosei has announced that Novartis Pharma KK launched Ultibro glycopyrronium/indacaterol inhalation capsules for the treatment of COPD. … [Read more...] about Japanese launches for Flutiform, Ultibro
Cornerstone launches Bethkis tobramycin inhalation solution
Cornerstone Therapeutics has launched Bethkis tobramycin inhalation solution for the treatment of cystic fibrosis patients with P. aeruginosa infections in the US, the company said. According to Cornerstone, one dose of Bethkis contains 300 mg of tobramycin in 4 mls of solution and can be delivered in about 15 minutes using a PARI LC Plus nebulizer. The company … [Read more...] about Cornerstone launches Bethkis tobramycin inhalation solution
Inhalation Asia 2013 presentations now available online
In accordance with their promise to provide open access to meeting materials, the organizers of Inhalation Asia 2013 have made all of the presentations from the meeting available on the meeting's website. The presentations include research that is applicable globally as well as papers specific to Asia such as "Inhalation delivery of traditional Chinese medicine … [Read more...] about Inhalation Asia 2013 presentations now available online
Aradigm appoints Juergen Froehlich new chief medical officer
Aradigm has announced the appointment of Juergen Froehlich as Chief Medical Officer. Froehlich is formerly Head of Regulatory Affairs at Vertex Pharmaceuticals where he was responsible for regulatory submissions for Kalydeco. Both of Aradigm's inhaled ciprofloxacin formulations, Pulmaquin and Lipoquin, were licensed by Grifols earlier this year. Aradigm … [Read more...] about Aradigm appoints Juergen Froehlich new chief medical officer
Particle Sciences to develop intranasal progesterone for BHR Pharma
Particle Sciences has announced that it has been awarded a contract for development of an intranasal progesterone formulation for the treatment of traumatic brain injury by BHR Pharma, a subsidiary of Besins Healthcare. Besins announced in April 2013 that it had licensed the Muco (μco) intranasal system from Shin Nippon Biomedical Laboratories (SNBL) for nasal … [Read more...] about Particle Sciences to develop intranasal progesterone for BHR Pharma
Timer Designs launches Advair/Seretide Compliance Cradle
Dutch pharmaceutical compliance specialist Timer Designs has announced the launch of the Compliance Cradle for Advair/Seretide Diskus inhalers. The device monitors the presence of the Diskus and alerts patients to take a dose of the medication if the inhaler remains situated in the cradle past the scheduled dosing time. The Compliance Cradle utilizes an optical … [Read more...] about Timer Designs launches Advair/Seretide Compliance Cradle